CD8A and neoplasm: Traditionally, it is believed that the number of tumor-infiltrating lymphocytes (TILs) serves as a predictor for immunotherapy susceptibility and prognosis; therefore, tumors are dichotomized into immune-hot (abundant infiltration of CD8+ T cells) and immune-cold (limited infiltration of CD8+ T cells) phenotypes [15–17].